HOOK (HOOKIPA Pharma) Net Margin %: -26.28% (As of Jun. 2025)


HOOK HOOKIPA Pharma Inc HOOK
50 GF Score
Price $1.15
View Full Analysis

What is HOOKIPA Pharma Net Margin %?

HOOKIPA Pharma HOOK 50 Net Margin % is -26.28% as of Jun. 2025. GuruFocus rates HOOK with a GF Score™ of 50/100. Among 939 Biotechnology companies, HOOKIPA Pharma ranks worse than 68.26% on this metric.

Net margin is calculated as Net Income divided by its Revenue. HOOKIPA Pharma's Net Income for the three months ended in Jun. 2025 was $-1.79 Mil. HOOKIPA Pharma's Revenue for the three months ended in Jun. 2025 was $6.80 Mil. Therefore, HOOKIPA Pharma's net margin for the quarter that ended in Jun. 2025 was -26.28%.

The historical rank and industry rank for HOOKIPA Pharma's Net Margin % or its related term are showing as below:


HOOK's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.29
* Ranked among companies with meaningful Net Margin % only.

HOOKIPA Pharma  (OTCPK:HOOK) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

HOOKIPA Pharma Net Margin % Related Terms

HOOKIPA Pharma Net Margin % Historical Data

* Premium members only.

The historical data trend for HOOKIPA Pharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HOOKIPA Pharma Net Margin % Chart

HOOKIPA Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
Get a 7-Day Free Trial -225.09 -410.15 -455.58 -405.29 -98.99

HOOKIPA Pharma Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,480.23 -294.30 -1,842.69 -769.81 -26.28

HOOK vs COCP, LNAI, CYCN: Net Margin % Comparison

For the Biotechnology subindustry, HOOKIPA Pharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HOOKIPA Pharma Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HOOKIPA Pharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where HOOKIPA Pharma's Net Margin % falls into.


HOOK
50GF Score
HOOKIPA Pharma Inc HOOK
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HOOKIPA Pharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

HOOKIPA Pharma's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-43.503/43.946
=-98.99 %

HOOKIPA Pharma's Net Margin for the quarter that ended in Jun. 2025 is calculated as

Net Margin=Net Income (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=-1.786/6.795
=-26.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -26.28% mean?
HOOKIPA Pharma (HOOK) has a Net Margin % of -26.28% as of Jun. 2025. Net margin is the ratio of total net income to net sales. View historical data on HOOKIPA Pharma and its competitors. According to the industry distribution chart, HOOKIPA Pharma ranks #641 out of 939 companies in the Biotechnology industry, placing it in the top 68.3%.
Is HOOKIPA Pharma's Net Margin % too high?
HOOKIPA Pharma's current Net Margin % is -26.28%. Based on the distribution chart, HOOKIPA Pharma ranks #641 out of 939 companies in the Biotechnology industry, which is below the industry midpoint. Overall, HOOKIPA Pharma has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does HOOKIPA Pharma's Net Margin % compare to COCP and LNAI?
According to the Biotechnology industry distribution chart, HOOKIPA Pharma ranks #641 out of 939 companies for Net Margin %. This places HOOKIPA Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on HOOKIPA Pharma and its competitors. HOOKIPA Pharma's current Net Margin % is -26.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HOOKIPA Pharma stock overvalued right now?
HOOKIPA Pharma (HOOK) has a current Net Margin % of -26.28%. The current Net Margin % is -26.28%. HOOKIPA Pharma's overall GF Score™ is 50/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For HOOKIPA Pharma (HOOK), the current Net Margin % is -26.28% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HOOKIPA Pharma Business Description

Address 350 Fifth Avenue, 72nd Floor, Suite 7240, New York, NY, USA, 10118
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. The company's product candidates are designed to induce specific, robust and durable CD8+ T cells and antibodies to eliminate cancers and serious infectious diseases. Its pipeline includes biological therapies for oncology, targeting human papillomavirus type 16-positive (HPV16+) cancers, KRAS mutated cancers, and other targets. In addition, It is also focused to develop therapies that are intended to provide functional cures for hepatitis B virus (HBV) and human immunodeficiency virus-1 (HIV-1).
50GF Score

Get the complete analysis for HOOK

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.15
Price